- CEO
- Klee Irwin
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- Address
- 5310 Beethoven Street Los Angeles CA United States of America 90066
- IPO Date
- Aug 27, 2021
- Business
- Irwin Naturals Inc. develops, manufactures, and distributes premium vitamins, nutritional supplements, and cannabidiol (CBD) products targeting health and wellness categories including mood and brain function, sleep support, sports performance, sexual health, immune support, weight management, women's health, and men's health; its core offerings comprise over 100 formulas such as liquid soft-gels, gummies, oils, creams, balms, roll-ons, and topicals enhanced by BioPerine Complex for superior absorption and potency, sold under the Irwin Naturals and Nature’s Secret brands through health food stores, mass market retailers, and e-commerce channels across the United States, Canada, and international markets. Founded in 1994 by Klee Irwin and headquartered at 5310 Beethoven Street in Los Angeles, California, the company also operates mental health clinics providing intravenous ketamine infusions for conditions like depression, PTSD, OCD, anxiety, bipolar disorder, migraines, and chronic pain syndromes including CRPS, RSD, and fibromyalgia. In August 2025, substantially all assets of Irwin Naturals Inc. and its affiliates were acquired by FitLife Brands Inc. for $42.5 million in a transaction under Section 363 of the U.S. Bankruptcy Code, funded primarily by a $35.75 million term loan and revolving credit facility from First Citizens Bank with the balance from cash reserves; this deal, which followed a voluntary Chapter 11 reorganization filing in August 2024, doubles FitLife's scale with projected combined annual revenue exceeding $120 million, streamlines operations, boosts e-commerce margins, and accelerates expansion into emerging wellness markets while assuming minimal liabilities.